发明名称 5-ARYLPYRIMIDINES AS ANTICANCER AGENTS.
摘要 <p>This invention relates to certain 5-arylpyrimidine compounds or a pharmaceutically acceptable salt thereof, and compositions containing said compounds or a pharmaceutically acceptable salt thereof, wherein said compounds are anti-cancer agents useful for the treatment of cancer in mammals. This invention further relates to a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal and further provides a method for the treatment or prevention of cancerous tumors that express multiple drug resistance (MDR) or are resistant because of MDR, in a mammal in need thereof which method comprises administering to said mammal an effective amount of said compounds or a pharmaceutically acceptable salt thereof. More specifically, the present invention relates to a method of treating or inhibiting the growth of cancerous tumor cells and associated diseases in a mammal in need thereof by promotion of microtubule polymerization which comprises administering to said mammal an effective amount of said compounds and pharmaceutically acceptable salts thereof.</p>
申请公布号 MXPA06003207(A) 申请公布日期 2006.06.23
申请号 MX2006PA03207 申请日期 2004.09.17
申请人 WYETH HOLDINGS CORPORATION 发明人 THAI HIEP NGUYEN
分类号 A61K31/505;A61K31/506;A61P35/00;C07D239/42;C07D239/48;C07D401/04;C07D403/04;C07D405/04;C07D409/04;(IPC1-7):A61K31/505 主分类号 A61K31/505
代理机构 代理人
主权项
地址